Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hollie J Jackson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cancer Discovery|December 6, 2015
Overcoming Antigen Escape with CAR T-cell TherapyHollie J Jackson, Renier J Brentjens
Nature Reviews. Clinical Oncology|March 23, 2016
Driving CAR T-cells forwardHollie J Jackson, Sarwish Rafiq, Renier J Brentjens
Molecular Therapy Oncolytics|September 15, 2016
Toxicity and management in CAR T-cell therapyChallice L Bonifant, Hollie J Jackson, Renier J Brentjens, et al.
Nature Biotechnology|August 14, 2018
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoSarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cancer Discovery|December 6, 2015
Overcoming Antigen Escape with CAR T-cell TherapyHollie J Jackson, Renier J Brentjens
Nature Reviews. Clinical Oncology|March 23, 2016
Driving CAR T-cells forwardHollie J Jackson, Sarwish Rafiq, Renier J Brentjens
Molecular Therapy Oncolytics|September 15, 2016
Toxicity and management in CAR T-cell therapyChallice L Bonifant, Hollie J Jackson, Renier J Brentjens, et al.
Nature Biotechnology|August 14, 2018
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivoSarwish Rafiq, Oladapo O Yeku, Hollie J Jackson, et al.
Pageof 1